Antibody targeting of E3 ubiquitin ligases for receptor degradationHadir Marei, Felipe de Sousa e Melo, Tao Sun et al.|Nature|2022Cited by 254
Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer’s Disease and Multiple SclerosisAinhoa Etxeberría, Christopher J. Bohlen, Yun‐An Shen et al.|Journal of Neuroscience|2024Cited by 28
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen Schauer, Anne Biever, Chang Hoon Cho et al.|Alzheimer s & Dementia|2024Cited by 5